MedTrace Logo

Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

NCT04704232 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-11-16

No results posted yet for this study

Summary

Phase 1 b placebo-controlled study in healthy volunteers to study safety, efficacy and pharmacokinetics of Topical ACD440 on normal skin, skin optimized for penetration and skin exposed to ultraviolet radiation

Conditions

Interventions

DRUG

ACD440

Double blind, parallel within subject comparison

DRUG

PLAC

Double blind, parallel within subject comparison

Sponsors & Collaborators

  • AlzeCure Pharma

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-12
Primary Completion
2021-03-10
Completion
2021-03-10

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04704232 on ClinicalTrials.gov